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Abstract
ABO discrepancies due to mixed-field agglutination are commonly seen with subgroups of A or B and ABOincompatible RBC transfusion in routine immunohematology laboratory. We report a 20 year old male with
minor ABO and Rh D mismatched hematopoietic stem cell transplantation presenting with blood group
chimerism. Column agglutination technique (CAT) had advantages in detecting mixed field agglutination than
other techniques used in routine blood grouping.
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Introduction
Chimerism is commonly referred as presence of two
genetically distinct populations within an individual.
Blood group chimerism is a usually rare phenomenon
which can be either congenital or acquired. The
common causes for acquired chimerism are ABO
incompatible blood transfusion, allogenic stem cells
and solid organ transplantation. They are usually
recognized at the time of blood grouping in form
of ABO discrepancies in forward group typing with
the presence of mixed-field red blood cell (RBC)
agglutination or discrepancies between forward and
reverse typing.1

Case Report
A 20-year-old male blood sample was received
for blood grouping without clinical details. Blood
grouping was performed using the electromagnetic
technology (Qwalys, Diagast) in a solid phase
red cell adherence assay (SPRCA) platform. The
forward grouping had no reactions with any type of
antibodies and the reverse grouping showed clumps
in A1 cells (Figure 1). Initially, type II ABO grouping
discrepancy with weak or missing B antigen was
suspected.
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Figure 2: Repeat ABO and Rh D typing in Column Agglutination
Technique

The possibility of a technical error was investigated
and the test on the group was repeated with tube
technique and column agglutination technique (CAT)
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(Biorad). The repeat tube technique confirmed the
presence of type II ABO discrepancy. On incubating
the tubes at 4˚C for 1 hour, a weak reaction was
noticed with Anti B and Anti D confirming B
subgroup and Rh D variant phenotype, respectively.
However, the CAT assay demonstrated presence of
two bands of cells in the Anti B and the Anti D in
forward group, suggesting mixed field agglutination
requiring detailed investigation (Figure 2).

and solid phase, most centres prefer automation in
pretransfusion testing due to increased sensitivity,
decreased personnel requirement, and ease of
archiving and transferring data.
Many articles have described the advantages of CAT
and SPRCA assay over conventional tube technique
but very limited articles discuss about mixed field
detection using these platforms. Summers et al.
compared three automated platforms (Microwell
/ CAT / SPRCA) for detecting mixed filed
agglutination reactions with control samples (100%
D+, 90% D+ with 10% D-, 50% D+ with 50% D-,
10% D+ with 90% D-, and 100% D-). SPRCA failed
to identify or flag any of the mixed field reactions.
With automated microwell technique, mixed field
reaction was clearly evident till 50% D+ control and
visual suspicion for mixed field was present with 90%
D+ and 10% D+ control. Automated CAT reported
these mixed field pattern as unclear reactions, and
visual inspection of the columns by the user clearly
identified the mixed-field reactions.3

Mixed-field agglutination in forward grouping
is usually noticed in subgroups of A or B and
ABO-incompatible RBC transfusion in routine
immunohematology laboratory. In this case, the
patient’s clinical details were not given initially and
found to have prior history of Minor ABO and Rh D
mismatched hematopoietic stem cell transplantation
three months back. The patient’s historical group
was retrieved and was found to be B Rh D Positive
(Figure 1) and the stem cell donor group was found
to be O Rh D Negative thus, confirming chimerism
due to ABO and Rh D incompatible transplantation
(Table 1).

CAT has better advantages in detecting mixedfield agglutination patterns as the antibody-coated
agglutinated RBCs can be trapped in the matrix
near the top while non-agglutinated RBCs will
pass through the matrix to the bottom. Thus,
clearly discriminating the presence of an acquired
population from the inherited ones.

Discussion
Blood group chimerism was an underreported entity.
With more bone marrow transplantation procedures
in the country blood group chimerism due to ABO
mismatch transplantation is increasing. Most
laboratories perform conventional tube technique
for blood grouping. Mixtures of 50/50% or 25/75%
cell populations are detected in tube technique;
however, a 5/95% minor cell population can be
missed in routine blood grouping.2 In present case,
tube technique at 4˚C, macroscopic reading of the
reaction with Anti B and Anti D was misinterpreted
as weak initially; later confirmed mixed field pattern
by microscopy. With newer automated methods
in the form of microwell, column agglutination

In a study by Greendyke and colleagues, skilled
blood bank technologist could detect only 12% of
mixed field agglutination patterns by tube technique
and only 50% of their staff was able to detect these
mixed filed patterns.4 Parker et al. in their study
reported that greater than 25% mixture of cells were
reported as reliable detection limit by tube technique
and this limit is largely driven by technological skill
and experience.5

Table 1: Summary of patient blood group in different methods

Patient Sample

Pre transplant Sample

Method

Anti A

Anti B

Anti D1

Anti D2

A1cells

B cells

O cells

SPRCA

0

0

0

0

4+

0

0

Tube at RT

0

0

0

ND

3+

0

0

Tube at 4˚C

0

Weak/ Mf

Weak/Mf

ND

3+

0

0

CAT

0

Mf

Mf

ND

3+

0

ND

SPRCA

0

4+

4+

4+

4+

0

0
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Conclusion
This case with the presence of separate group O/B,
D+/- RBC population in grouping emphasize that
chimerism due to ABO and Rh D incompatible
transplantation is not uncommon any more. The
mixed field agglutination reaction was missed with
SPRCA while CAT clearly displayed the reaction
pattern which helped in resolving the discrepancy
early. For resolving grouping discrepancies, all
discrepant blood groups should be performed with
minimum of two different platforms. Most often
the causes for mixed field reactions in ABO and Rh
D grouping can be easily ascertained from patient
clinical history. All blood samples with clinical
history suspicion for blood group chimerism should
be confirmed with CAT platform. Adequate training
should be catered to the lab technicians to detect
mixed field reactions in blood grouping. Resolving
such discrepancies require proper clinical details
especially recent transfusion or transplantation in
the blood request form; which will prevent undue
delay in issue of report or blood components.
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